In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum

Abstract Background Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted...

Full description

Bibliographic Details
Main Authors: Xiaoli Wang, Dan Yu, Chunxiang Li, Tingzheng Zhan, Tingting Zhang, Huihui Ma, Jing Xu, Chaoming Xia
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Parasites & Vectors
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13071-019-3442-7
_version_ 1818159478722265088
author Xiaoli Wang
Dan Yu
Chunxiang Li
Tingzheng Zhan
Tingting Zhang
Huihui Ma
Jing Xu
Chaoming Xia
author_facet Xiaoli Wang
Dan Yu
Chunxiang Li
Tingzheng Zhan
Tingting Zhang
Huihui Ma
Jing Xu
Chaoming Xia
author_sort Xiaoli Wang
collection DOAJ
description Abstract Background Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted the development of new, alternative drugs for repeated use in endemic areas where PZQ efficacy against strains of Schistosoma is reduced. A hybrid drug containing different pharmacophores within a single molecule is a promising strategy. Our earlier in vivo studies showed the significant antiparasitic activity of a praziquantel derivative, DW-3-15, against Schistosoma japonicum. In the present study, DW-3-15 was synthesized in large amounts by a pharmaceutical company and its schistosomicidal efficacy and stability were further confirmed. Parameters such as parasite viability, pairing and oviposition were evaluated in vitro. An in vivo study was conducted to assess the effect of commercial DW-3-15 on worm burden, egg production and diameter of granulomas. Additionally, to gain insight into the mechanism of action for DW-3-15, morphological changes in the tegument of S. japonicum were also examined. Results The in vitro study showed the antiparasitic activity of DW-3-15 against S. japonicum, with significant reductions in viability of adult and juvenile worms, worm pairings and egg output. Compared to PZQ, DW-3-15 induced similar ultrastructural changes and evident destruction of the tegument surface in male worms. In vivo, the oral administration of DW-3-15 at a dose of 400 mg/kg per day for five consecutive days in mice significantly reduced the total worm burden and number of eggs in the liver. Histological analysis of the livers showed a marked reduction in the average diameter of the egg granuloma. Conclusions Our findings suggest that DW-3-15, a PZQ derivative with the prospect of commercial production, can be developed as a potential promising schistosomicide.
first_indexed 2024-12-11T15:46:37Z
format Article
id doaj.art-47a7cc73a2ce45969895e80a5f903a28
institution Directory Open Access Journal
issn 1756-3305
language English
last_indexed 2024-12-11T15:46:37Z
publishDate 2019-05-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj.art-47a7cc73a2ce45969895e80a5f903a282022-12-22T00:59:41ZengBMCParasites & Vectors1756-33052019-05-0112111310.1186/s13071-019-3442-7In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicumXiaoli Wang0Dan Yu1Chunxiang Li2Tingzheng Zhan3Tingting Zhang4Huihui Ma5Jing Xu6Chaoming Xia7Department of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityDepartment of Parasitology, Medical College of Soochow UniversityAbstract Background Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted the development of new, alternative drugs for repeated use in endemic areas where PZQ efficacy against strains of Schistosoma is reduced. A hybrid drug containing different pharmacophores within a single molecule is a promising strategy. Our earlier in vivo studies showed the significant antiparasitic activity of a praziquantel derivative, DW-3-15, against Schistosoma japonicum. In the present study, DW-3-15 was synthesized in large amounts by a pharmaceutical company and its schistosomicidal efficacy and stability were further confirmed. Parameters such as parasite viability, pairing and oviposition were evaluated in vitro. An in vivo study was conducted to assess the effect of commercial DW-3-15 on worm burden, egg production and diameter of granulomas. Additionally, to gain insight into the mechanism of action for DW-3-15, morphological changes in the tegument of S. japonicum were also examined. Results The in vitro study showed the antiparasitic activity of DW-3-15 against S. japonicum, with significant reductions in viability of adult and juvenile worms, worm pairings and egg output. Compared to PZQ, DW-3-15 induced similar ultrastructural changes and evident destruction of the tegument surface in male worms. In vivo, the oral administration of DW-3-15 at a dose of 400 mg/kg per day for five consecutive days in mice significantly reduced the total worm burden and number of eggs in the liver. Histological analysis of the livers showed a marked reduction in the average diameter of the egg granuloma. Conclusions Our findings suggest that DW-3-15, a PZQ derivative with the prospect of commercial production, can be developed as a potential promising schistosomicide.http://link.springer.com/article/10.1186/s13071-019-3442-7PraziquantelSchistosoma japonicumSchistosomicide
spellingShingle Xiaoli Wang
Dan Yu
Chunxiang Li
Tingzheng Zhan
Tingting Zhang
Huihui Ma
Jing Xu
Chaoming Xia
In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
Parasites & Vectors
Praziquantel
Schistosoma japonicum
Schistosomicide
title In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
title_full In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
title_fullStr In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
title_full_unstemmed In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
title_short In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
title_sort in vitro and in vivo activities of dw 3 15 a commercial praziquantel derivative against schistosoma japonicum
topic Praziquantel
Schistosoma japonicum
Schistosomicide
url http://link.springer.com/article/10.1186/s13071-019-3442-7
work_keys_str_mv AT xiaoliwang invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT danyu invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT chunxiangli invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT tingzhengzhan invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT tingtingzhang invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT huihuima invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT jingxu invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum
AT chaomingxia invitroandinvivoactivitiesofdw315acommercialpraziquantelderivativeagainstschistosomajaponicum